Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present BioNovelus, Inc. (OTC: ONOV).

Full DD Report for ONOV

You must become a subscriber to view this report.


Recent News from (OTC: ONOV)

BioNovelus Announces Marvin R Clark Leaving the Board of Directors, and Welcomes Michael D Goodman as New Treasurer and Member of Board of Directors
Phoenix, Aug. 08, 2018 (GLOBE NEWSWIRE) --  / BioNovelus, Inc. (OTC Pink: ONOV) today announced that Marvin R Clark has stepped down from the Company's board of directors, and as Treasurer for personal reasons, effective June 22, 2018. "After six years of pursuing a positive chang...
Source: GlobeNewswire
Date: August, 08 2018 07:00
BIONOVELUS CORRECTS RELEASE DATED AUGUST 3, 2018 AND HAS NOT ENTERED INTO ANY SETTLEMENT AGREEMENT WITH L2 CAPITAL
FOR IMMEDIATE CORRECTIVE RELEASE — Phoenix, Aug. 07, 2018 (GLOBE NEWSWIRE) -- — As previously announced, BioNovelus (ONOV) (the “ Company ”) did enter into a Claim Purchase Agreement on June 30, 2018 with L2 Capital, LLC (“ L2 ”) to ...
Source: GlobeNewswire
Date: August, 07 2018 09:40
BIONOVELUS ENTERS INTO SETTLEMENT AND MUTUAL RELEASE AGREEMENT AND RELATED STIPULATED JUDGMENT WITH L2 CAPITAL, LLC
FOR IMMEDIATE RELEASE —Phoenix, Aug. 03, 2018 (GLOBE NEWSWIRE) -- — BioNovelus (OTC Pink: ONOV) (the “ Company ”) entered into a Claim Purchase Agreement on June 30, 2018 with L2 Capital, LLC (“ L2 ”) to make payments toward certain past due ...
Source: GlobeNewswire
Date: August, 03 2018 11:54
BioNovelus, Inc. reports Q1 results
BioNovelus, Inc. ( OTCPK:ONOV ): Q1 Net loss of $0.10M Press Release More news on: BioNovelus, Inc., Earnings news and commentary, ,
Source: SeekingAlpha
Date: May, 14 2018 23:57
BIONOVELUS' FIRST QUARTER REPORTS
FOR IMMEDIATE RELEASE — Phoenix, May 14, 2018 (GLOBE NEWSWIRE) -- / BioNovelus (OTC Pink: ONOV) has published today its first quarter of 2018 financial statements and report. This information is attached to this Press Release, and also available at  https://bionovelu...
Source: GlobeNewswire
Date: May, 14 2018 20:44
BioNovelus Receives Organic Certification for CR-10®
FOR IMMEDIATE RELEASE — Phoenix, April 26, 2018 (GLOBE NEWSWIRE) -- — BioNovelus is proud to announce that its flagship product CR-10®, a non-toxic, organic fungicide has received the organic certification from Mayacert. Mayacert, the leading company in the certif...
Source: GlobeNewswire
Date: April, 26 2018 08:00
BIONOVELUS C.I.O.DEPARTURE
FOR IMMEDIATE RELEASE / Phoenix, March 02, 2018 (GLOBE NEWSWIRE) -- / BioNovelus, Inc. (ONOV), whose CR-10® Biofungicide is a non-toxic solution for safe and effective pre- and post-harvest applications, is announcing effective immediately, that Anthony Parkinson, Chief Informati...
Source: GlobeNewswire
Date: March, 02 2018 07:00
BioNovelus agrees to Co-Directorship and advisory with Meroe Capital Group Ltd.
FOR IMMEDIATE RELEASE — Phoenix, Nov. 14, 2017 (GLOBE NEWSWIRE) -- — BioNovelus (ONOV) has today announced the retention of New York-based Meroe Capital Group Ltd. In the structure of the deal, BioNovelus will become a client of Meroe Capital’s prestigious “H2...
Source: GlobeNewswire
Date: November, 14 2017 06:00
"Mission" of BioNovelus' CR-10 Leading to Healthier Crops in Central America
FOR IMMEDIATE RELEASE — Phoenix, Oct. 18, 2017 (GLOBE NEWSWIRE) -- — An internally created promotional video is helping BioNovelus President and CEO Jean Ekobo spread the word about the company’s non-toxic, organic fungicide and the very strong early results that f...
Source: GlobeNewswire
Date: October, 18 2017 07:30
BIONOVELUS' EDUCATIONAL SERIES LEADING TO SALES
FOR IMMEDIATE RELEASE — Phoenix, Oct. 12, 2017 (GLOBE NEWSWIRE) -- / The “Introduction to Disruptive Agricultural Solutions” events that BioNovelus (OTC Pink: ONOV) began co-hosting in Guatemala in the summer are continuing with great success. The well-attended ed...
Source: GlobeNewswire
Date: October, 12 2017 20:32

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-13N/A0.015N/AN/A0
2018-12-120.0150.0150.0150.0155,800
2018-12-110.01170.014350.014350.011724,900
2018-12-100.0180.0180.0180.01813,888
2018-12-070.020.0190.020.01950,000

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-103,88813,88827.9954Cover
2018-12-0750,00050,000100.0000Short
2018-12-0610,000154,9106.4554Cover
2018-12-038,80033,00026.6667Cover
2018-11-2010,00010,000100.0000Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ONOV.


About BioNovelus, Inc. (OTC: ONOV)

Logo for BioNovelus, Inc. (OTC: ONOV)

BioNovelus, Inc. OTC Pink: ONOV is a bioscience company that honors the environment with an innovative, cost effective and disruptive technology based solution to agricultural and sanitizing problems. BIONOVELUS is transforming the billion agriculture pesticide industry with CR a non toxic, biodegradable, and highly effective system of defense that is capable of replacing chemical treatments and postharvest sanitizers. Our product can replace multiple products with fewer applications than its toxic competitors without sacrificing quality. Most importantly, when farmers use CR , they experience less crop loss and food waste, increased revenue, and better economic security for communities that depend on agricultural production, without damaging the health of agricultural workers or the environment.

 

 

 

Current Management

  • Jean Machetel Ekobo Embesse / CEO
    • Founder of BioNovelus, Inc. Visionary. Enthusiastic. Driven. Jean created a team with top level executives and experts. Accomplished Business Owner and Chef, he has founded four companies. He knows how to choose and lead teams through good and tough times, and his teams like to ago the extra mile for him. His communication style is straight forward, and shows credibility. In his Wellness and Health Nutrition company, he built successful distribution channels in France, Belgium, Canada and United States. His international sales experience led him to develop the right business model for his green bio science company. Jean won numerous awards over the past years for business management, international sales development, and for activities in the hospitality industry, including the Exceptional Competency Visa awarded by the US Homeland Security Administration to High Achievers in their fields. Jean speaks fluent French and English, and Cameroonian dialect. He is currently learning Spanish. He is a member of the Global Chamber of Commerce.
  • Nathalie Fournier Ekobo / VP, Mkt.
    • years as an international Marketing and Sales Manager, and Business Consultant. Nathalie s extensive experience in multiple industries has been focused on international on the ground sales, designing and implementation of marketing campaigns which resulted in millions for French and American companies. As an International Communication Manager and Corporate Trainer/Speaker, she has done presentations in over countries. Her specialties include: Branding, Social Media, Integrated Marketing Strategy, Campaign Development and Implementation, and International Sales. Nathalie holds a Masters in Business from the CPEI, an International Business School inside La Sorbonne University, Paris, France, and a Masters in Russian from La SorbonneParis IV University. She speaks English, French, Russian, some German, and she is currently learning Spanish.
  • Jean Machetel Ekobo Embesse / Chairman
    • Founder of BioNovelus, Inc. Visionary. Enthusiastic. Driven. Jean created a team with top level executives and experts. Accomplished Business Owner and Chef, he has founded four companies. He knows how to choose and lead teams through good and tough times, and his teams like to ago the extra mile for him. His communication style is straight forward, and shows credibility. In his Wellness and Health Nutrition company, he built successful distribution channels in France, Belgium, Canada and United States. His international sales experience led him to develop the right business model for his green bio science company. Jean won numerous awards over the past years for business management, international sales development, and for activities in the hospitality industry, including the Exceptional Competency Visa awarded by the US Homeland Security Administration to High Achievers in their fields. Jean speaks fluent French and English, and Cameroonian dialect. He is currently learning Spanish. He is a member of the Global Chamber of Commerce.

Current Share Structure

  • Market Cap: $4,961,696 - 03/15/2018
  • Authorized: 500,000,000 - 02/28/2018
  • Issue and Outstanding: 112,765,827 - 02/28/2018
  • Float: 13,200,588 - 09/30/2017

 


Recent Filings from (OTC: ONOV)

Quarterly Report - 3Q Report
Filing Type: Quarterly Report - 3Q ReportFiling Source: OTC Markets
Filing Date: November, 14 2017
Quarterly Report - Third Quarter Financials 2017
Filing Type: Quarterly Report - Third Quarter Financials 2017Filing Source: OTC Markets
Filing Date: November, 14 2017

 

 


Daily Technical Chart for (OTC: ONOV)

Daily Technical Chart for (OTC: ONOV)


Stay tuned for daily updates and more on (OTC: ONOV)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ONOV)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ONOV is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ONOV and does not buy, sell, or trade any shares of ONOV. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/